Valuation: MELA Sciences Inc

Market Cap 588 534.2 493.57 445.83 841.35 55.21T 870.95 5.94T 2.35T 29.63T 2.21T 2.16T 93.85T P/E 2024
-1.1x
P/E 2025 -0.94x
Enterprise Value 83.57L 75.92L 70.15L 63.36L 1.2Cr 78Cr 1.24Cr 8.44Cr 3.34Cr 42Cr 3.14Cr 3.07Cr 133.38Cr EV / Sales 2024
0.64x
EV / Sales 2025 0.51x
Free-Float
71.75%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 12/07/2026
Chief Operating Officer - 14/11/2023
Comptroller/Controller/Auditor 51 13/11/2024
Director TitleAgeSince
Chairman 58 03/07/2023
Director/Board Member 87 29/05/2018
Director/Board Member 62 27/03/2024
Change 5-day change 1-year change 3-year change Capi.($)
-1.27%-4.20%+19.46%+46.32% 26TCr
-1.33%-2.22%+3.93%+9.95% 16TCr
-1.32%-4.95%-20.34%+44.02% 15TCr
-1.47%-0.75%-57.45%-20.08% 6.33TCr
-0.04%+2.29%+24.11%+58.75% 6.16TCr
-0.74%+1.77%+4.60%-12.67% 5.39TCr
-0.60%-4.02%+17.78%+51.43% 4.88TCr
-0.75%-2.32%+2.02%+70.70% 4.85TCr
-1.48%-4.88%+19.51%+70.33% 4.46TCr
Average -1.00%-0.29%+1.51%+35.42% 10TCr
Weighted average by Cap. -1.13%-0.31%+2.77%+34.70%

Financials

2024 2025
Net sales 3.36Cr 3.05Cr 2.82Cr 2.54Cr 4.8Cr 315.13Cr 4.97Cr 34Cr 13Cr 169.11Cr 13Cr 12Cr 535.68Cr 3.07Cr 2.79Cr 2.58Cr 2.33Cr 4.39Cr 288.22Cr 4.55Cr 31Cr 12Cr 154.67Cr 12Cr 11Cr 489.93Cr
Net income -1.01Cr -91.63L -84.66L -76.47L -1.44Cr -95Cr -1.49Cr -10Cr -4.03Cr -51Cr -3.78Cr -3.7Cr -160.98Cr -62.61L -56.88L -52.56L -47.47L -89.59L -59Cr -92.74L -6.32Cr -2.5Cr -32Cr -2.35Cr -2.3Cr -100Cr
Net Debt 91.78L 83.38L 77.04L 69.59L 1.31Cr 86Cr 1.36Cr 9.26Cr 3.67Cr 46Cr 3.44Cr 3.37Cr 146.49Cr 83.56L 75.91L 70.14L 63.36L 1.2Cr 78Cr 1.24Cr 8.43Cr 3.34Cr 42Cr 3.14Cr 3.07Cr 133.37Cr
Logo MELA Sciences Inc
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Employees
-